Page 36 - Vitamin D and Cancer

1 Vitamin D: Synthesis and Catabolism 23

94. Smirnoff P, Liel Y, Gnainsky J, Shany S, Schwartz B (1999) The protective effect of estrogen
against chemically induced murine colon carcinogenesis is associated with decreased CpG
island methylation and increased mRNA and protein expression of the colonic vitamin D
receptor. Oncol Res 11(6):255–264
95. Khorchide M, Lechner D, Cross HS (2005) Epigenetic regulation of vitamin D hydroxylase
expression and activity in normal and malignant human prostate cells. J Steroid Biochem
Mol Biol 93(2–5):167–172
96. Wang L, Persons KS, Jamieson D et al (2008) Prostate 25-hydroxyvitamin D-1alpha-
hydroxylase is up-regulated by suberoylanilide hydroxamic acid (SAHA), a histone deacety-
lase inhibitor. Anticancer Res 28(4A):2009–2013
97. Banwell CM, Singh R, Stewart PM, Uskokovic MR, Campbell MJ (2003) Antiproliferative
signalling by 1, 25(OH)2D3 in prostate and breast cancer is suppressed by a mechanism
involving histone deacetylation. Recent Results Cancer Res 164:83–98
98. Cho E, Smith-Warner SA, Spiegelman D et al (2004) Dairy foods, calcium, and colorectal
cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst 96(13):1015–1022
99. Grau MV, Baron JA, Sandler RS et al (2003) Vitamin D, calcium supplementation, and
colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 95(23):1765–1771
100. Holt PR, Bresalier RS, Ma CK et al (2006) Calcium plus vitamin D alters preneoplastic
features of colorectal adenomas and rectal mucosa. Cancer 106(2):287–296
101. Nehring JA, Zierold C, DeLuca HF (2007) Lithocholic acid can carry out in vivo functions
of vitamin D. Proc Natl Acad Sci USA 104(24):10006–10009
102. Canaff L, Hendy GN (2002) Human calcium-sensing receptor gene. Vitamin D response
elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvi-
tamin D. J Biol Chem 277(33):30337–30350
103. Cross HS, Kallay E, Lechner D, Gerdenitsch W, Adlercreutz H, Armbrecht HJ (2004)
Phytoestrogens and vitamin D metabolism: a new concept for the prevention and therapy of
colorectal, prostate, and mammary carcinomas. J Nutr 134(5):1207S–1212S
104. Bises G, Bajna E, Manhardt T, Gerdenitsch W, Kallay E, Cross HS (2007) Gender-specific
modulation of markers for premalignancy by nutritional soy and calcium in the mouse colon.
J Nutr 137(1):211S–215S
105. An J, Tzagarakis-Foster C, Scharschmidt TC, Lomri N, Leitman DC (2001) Estrogen recep-
tor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens.
J Biol Chem 276(21):17808–17814
106. Kuiper GG, Lemmen JG, Carlsson B et al (1998) Interaction of estrogenic chemicals and
phytoestrogens with estrogen receptor beta. Endocrinology 139(10):4252–4263
107. Swami S, Krishnan AV, Moreno J, Bhattacharyya RB, Peehl DM, Feldman D (2007)
Calcitriol and genistein actions to inhibit the prostaglandin pathway: potential combination
therapy to treat prostate cancer. J Nutr 137(1 Suppl):205S–210S
108. Cross HS, Kallay E, Farhan H, Weiland T, Manhardt T (2003) Regulation of extrarenal
vitamin D metabolism as a tool for colon and prostate cancer prevention. Recent Results
Cancer Res 164:413–425
109. Swami S, Krishnan AV, Peehl DM, Feldman D (2005) Genistein potentiates the growth
inhibitory effects of 1, 25-dihydroxyvitamin D3 in DU145 human prostate cancer cells:
role of the direct inhibition of CYP24 enzyme activity. Mol Cell Endocrinol 241(1–2):
49–61
110. Pfeiffer CM, Johnson CL, Jain RB et al (2007) Trends in blood folate and vitamin B-12
concentrations in the United States, 1988–2004. Am J Clin Nutr 86(3):718–727
111. Keyes MK, Jang H, Mason JB et al (2007) Older age and dietary folate are determinants of
genomic and p16-specific DNA methylation in mouse colon. J Nutr 137(7):1713–1717
112. Choi SW, Mason JB (2000) Folate and carcinogenesis: an integrated scheme. J Nutr
130(2):129–132
113. Giovannucci E, Stampfer MJ, Colditz GA et al (1998) Multivitamin use, folate, and colon
cancer in women in the Nurses’ Health Study. Ann Intern Med 129(7):517–524